Population-scale burden analysis of rare damaging coding variants identifies novel risk genes for Alzheimer's disease and Parkinson's disease
Le Guen, Y.; Pena-Tauber, A.; Catoia Pulgrossi, R.; Park, J.; Orias, H.; Greicius, M. D.
Show abstract
Alzheimers disease and related dementias (ADRD)1 and Parkinsons disease and related disorders (PDRD)2 have substantial genetic contributions, yet the role of rare damaging coding variants remains incompletely characterized at population scale3-6. We performed gene-based burden testing of rare loss-of-function and deleterious missense variants using whole-genome sequencing data from large population biobanks combined with disease-specific sequencing cohorts, leveraging proxy phenotypes to maximize statistical power for late-onset neurodegenerative diseases7. We confirmed rare variant burden in established ADRD genes (ABCA7, PSEN1, ADAM10, ATP8B4, GRN, SORL1, TREM2, SHARPIN) and PDRD genes (GBA1, LRRK2). We additionally identified novel associations in ADRD (IMPA2, PMM2, SYNE1, CHRNA4, FCGR1A) and PDRD (ANKRD27, CCL7, USP19, SKP1, KANSL3). The strongest signal was observed for ANKRD27, where damaging variants clustered within domains mediating interactions with Rab GTPases and retromer components. Our results demonstrate the power of population-scale sequencing combined with proxy phenotypes to identify rare coding risk genes for neurodegenerative diseases.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies 96%
- Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer’s disease and highlights potential translational opportunities 96%
- Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 96%
Similar papers in this journal
- Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease 96%
- Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease 95%
- Multi-ancestry study of the genetics of problematic alcohol use in >1 million individuals 94%
Similar papers in this journal
Similar papers in this journal
- 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinsons disease are associated with LRRC37A/2 expression in astrocytes 96%
- Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy 96%
- Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.